Literature DB >> 16557771

Cryptococcus neoformans IV. The Not-So-Encapsulated Yeast.

F Farhi1, G S Bulmer, J R Tacker.   

Abstract

Nonencapsulated cells of Cryptococcus neoformans which may have a diameter of less than 4 mum are capable of producing experimental cryptococcosis in mice. It has been established that this relatively small, nonencapsulated yeast can exist in soil. In this form, the organism could be more readily disseminated by air currents, and it is more likely to be inhaled into the lungs than the larger encapsulated yeast. Nonencapsulated cells produce sufficient capsular material to inhibit phagocytosis by 50% when incubated for 5 to 10 hr with human lung tissue in vitro. The general assumption that the encapsulated cells are the etiological agent of naturally acquired cryptococcosis may have to be revised.

Entities:  

Year:  1970        PMID: 16557771      PMCID: PMC415937          DOI: 10.1128/iai.1.6.526-531.1970

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

Review 1.  ASPECTS OF BACTERIAL RESPONSE TO THE IONIC ENVIRONMENT.

Authors:  A D BROWN
Journal:  Bacteriol Rev       Date:  1964-09

2.  Distribution and deposition of inhaled particles in respiratory tract.

Authors:  T F HATCH
Journal:  Bacteriol Rev       Date:  1961-09

3.  The chemical composition of the cell and cell wall of some halophilic bacteria.

Authors:  W R SMITHIES; N E GIBBONS; S T BAYLEY
Journal:  Can J Microbiol       Date:  1955-10       Impact factor: 2.419

4.  Influence of Particle Size upon the Retention of Particulate Matter in the Human Lung.

Authors:  J H Brown; K M Cook; F G Ney; T Hatch
Journal:  Am J Public Health Nations Health       Date:  1950-04

5.  A qualitative analysis of capsular polysaccharides from Cryptococcus neoformans by filter paper chromatography.

Authors:  E E EVANS; J W MEHL
Journal:  Science       Date:  1951-07-06       Impact factor: 47.728

6.  An evaluation of various environmental factors affecting the propagation of Cryptococcus neoformas.

Authors:  C M Ishaq; G S Bulmer; F G Felton
Journal:  Mycopathol Mycol Appl       Date:  1968-07-12

7.  Investigations on the structure of the capsular polysaccharide from Cryptococcus neoformans type B.

Authors:  A Blandamer; I Danishefsky
Journal:  Biochim Biophys Acta       Date:  1966-04-25

8.  Cryptococcus neoformans. 3. Inhibition of phagocytosis.

Authors:  G S Bulmer; M D Sans
Journal:  J Bacteriol       Date:  1968-01       Impact factor: 3.490

9.  Cryptococcus neoformans. II. Phagocytosis by human leukocytes.

Authors:  G S Bulmer; M D Sans
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

  9 in total
  39 in total

1.  Dimorphism and haploid fruiting in Cryptococcus neoformans: association with the alpha-mating type.

Authors:  B L Wickes; M E Mayorga; U Edman; J C Edman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Neurovirulence of Cryptococcus neoformans determined by time course of capsule accumulation and total volume of capsule in the brain.

Authors:  A Pool; L Lowder; Y Wu; K Forrester; J Rumbaugh
Journal:  J Neurovirol       Date:  2013-06-04       Impact factor: 2.643

Review 3.  Twenty-five years with Cryptococcus neoformans.

Authors:  G S Bulmer
Journal:  Mycopathologia       Date:  1990-02       Impact factor: 2.574

4.  Persistence of infection in mice inoculated intranasally with Cryptococcus neoformans.

Authors:  D A Anderson; H M Sagha
Journal:  Mycopathologia       Date:  1988-12       Impact factor: 2.574

5.  Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations.

Authors:  Leonardo Nimrichter; Susana Frases; Leonardo P Cinelli; Nathan B Viana; Antonio Nakouzi; Luiz R Travassos; Arturo Casadevall; Marcio L Rodrigues
Journal:  Eukaryot Cell       Date:  2007-06-15

Review 6.  Immunity in cryptococcosis: an overview.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1982-03-19       Impact factor: 2.574

7.  Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells.

Authors:  S Schelenz; R Malhotra; R B Sim; U Holmskov; G J Bancroft
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule.

Authors:  A S Ibrahim; S G Filler; M S Alcouloumre; T R Kozel; J E Edwards; M A Ghannoum
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  Pathogenesis, lethality, and immunizing effect of experimental cutaneous cryptococcosis.

Authors:  M A Dykstra; L Friedman
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

10.  Cryptococcus neoformans: pseudohyphal forms surviving culture with Acanthamoeba polyphaga.

Authors:  J B Neilson; M H Ivey; G S Bulmer
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.